Eclampsia in Maharat Nakhon Ratchasima Hospital

Article Sidebar

PDF
Published: May 7, 2018

Main Article Content

Siraya Kitiyodom
Medical Physician, Professional Level, Department of Obstetrics and Gynecology, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand

Abstract

Background: Preeclampsia, characterized by endothelial malfunction and vasospasm, is defined as new onset of hypertension after 20 weeks of gestation age with proteinuria. Quarter of cases are severe preeclampsia which have severe complications including generalizes tonic-clonic convulsion or eclampsia. Preeclampsia and eclampsia is one of the three leading causes of maternal morbidity and mortality worldwide. In Maharat Nakhon Ratchasima Hospital, annual prevalence of severe preeclampsia is more than 200-300 cases. The objective of this study is to determine the inci dence of eclampsia, the characteristics and the complications of eclampsia in pregnancy patients in Maharat Nakhon Ratchasima Hospital.
Objective: To determine the incidence of eclampsia, characteristics and complications of eclampsia in pregnancy patientsin which associated maternal and perinatal outcomes in Maharat Nakhon Ratchasima Hospital.
Setting: Obstetrics and gynecology department of Maharat Nakhon Ratchasima Hospital.
Study design: Descriptive retrospective hospital-based study
Methods: A descriptive retrospective study was conducted by a retrospective review of 31 medical records of eclampsiapatients hospitalized in Maharat Nakhon Ratchasima Hospital during October 2011 to September 2013.
Results: There were 734 severe preeclampsia patients during study period, which 31 cases had develope declampsia (15.4 per 10000 deliveries). Eclampsia was the mostly found among the teenage group (54.8%), primigravida (74.2%), preterm (67.7%), and overweight (61.3%). Twenty-nine (93.5%) had history of headache before seizure and two eclampsia patients had no proteinuria which is the criteria fordiagnosis of preeclampsia. Sixteen eclampsia patients had recurrent seizure. Fourteen eclampsia patients had seizure after giving intravenous magnesium sulfate according to sub-therapeutic serum magnesium level and 85.7% of cases associated with overweight. There was one patient diedduring the study period due to intracerebral hemorrhage after seizure. Twenty-one babies (67.7%) had low birth weight.
Conclusion: The incidence of eclampsia was not high but still a major cause of maternal mortality and serious complications. Therefore, development of systems for access antenatal care, early diagnosis and treatments are necessary in order to achieve the effective medical management.

Article Details

How to Cite
Kitiyodom, S. (2018). Eclampsia in Maharat Nakhon Ratchasima Hospital. MEDICAL JOURNAL OF SISAKET SURIN BURIRAM HOSPITALS, 29(3), 129–138. retrieved from https://he02.tci-thaijo.org/index.php/MJSSBH/article/view/122515
Issue
Vol. 29 No. 3 (2014): September - December 2014
Section
Original Articles

References

1. Cunningham FG, Leveno KJ, Bloom SL, et al. Pregnancy Hypertension. In: Cunningham FG, Williams JW, editors. Williams Obstetrics. 23th ed. New York : McGraw-Hill Medical; 2010.

2. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004;190:6:1520-6.

3. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-67.

4. Siabai BM, Abdella TN, Spinnato JA, Anderson GD. Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynaecol 1986;154: 581-6.

5. Ngoc NT, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, Zavaleta N, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006;84:9:699-705.

6. Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, Leon JA, et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011;118:5:987-94.

7. Thornton C, Dahlen H, Korda A Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol 2013;208(6):476.

8. Chinayon p. Clinical management and outcome of eclampsia at Rajavithi Hospital. J Med Assoc Thai 1998; 81:8:579-85.
9. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-75.

10. Marti JJ, Hermann U. Immunogestosis: a new etiologic concept of “essential” EPH gestosis, with special consideration of the primigravid patient. Am J Obstet Gynecol 1977;128:489-93.

11. Liu CM, Chang SD, Cheng PJ. Relationship between prenatal care and maternal complications in women with preeclampsia: implications for continuity and discontinuity of prenatal care. Taiwan J ObstetGynecol 2012;51:4:576-82.

12. S Kitiyodom, P Tongswatwong. Pregnancy Outcomes of Parturients with Excessive-weight in Maharat Nakorn Ratchasima Hospital. Thai J Obstet Gynaecol 2008;16:214-20.

13. Ob-Gyns Issue Task Force Report on Hypertension in Pregnancy - ACOG [Internet], [cited 2014 Sep 20], Available from : URL:https://www.acog.org/About- ACOG/News-Room/News-Releases/ 2013/Ob-Gyns-lssue-Task-Force- Report-on-Hypertension-in-Pregnancy

14. Dekker GA, Sibai BM. Primary, secondary, and tertiary prevention of preeclampsia. The Lancet 2001;357:209-15.

15. Tudela CM, Mclntire DD, Alexnder JM. Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis. Obstet Gynecol 2013;121:314-20.

16. Quamme GA, Dirks JH. Magnesium metabolism. In: Narins RG, ed. Clinical disorders of fluid and electrolyte metabolism. 5th ed. New York : McGraw Hill; 1994: p.373.